| | Marker | Sorting method | Effect | Reference |
| | CD49f | FACS | ↑ Clonogenity,
↑ proliferation,
↑ migration,
↑ multilineage differentiation, | [26] |
| | CD49f | FACS | ↑ Colony forming,
↑ adipogenic and osteogenic differentiation | [25] |
| | CD49f | FASC | ↑ Self-renewal,
↑ spheres formation,
↑ adipogenic and osteogenic differentiation | [27] |
| | CD49f | MASC | ↑ Adhesion,
↑ proliferation,
↑ adipogenic and osteogenic differentiation,
↑ migration,
↑ antiapoptotic potential | [28] |
| | CD271 | FACS | ↑ Clonogenicity,
↑ osteogenic differentiation | [30] |
| | CD271 | FACS | ↑ Proliferation, | [31] |
| | CD271 | FACS | ↑ Proliferation,
↓ osteogenic and adipose differentiation | [47] |
| | CD271 | MACS | ↑ Neuronal and glial differentiation,
↑ migration toward islets and islet-like cell clusters | [32] |
| | CD271 | MACS | ↑ Pluripotent genes expression | [48] |
| | CD271 | MACS | No changes in multipotent differentiation in vitro,
↑ osteochondral repair in vivo,
↓ angiogenesis in vitro and in vivo | [49] |
| | CD271 | MACS | ↑ Adipogenesis, chondrogenesis, osteogenesis | [33] |
| | CD349 | FACS | ↓ Angiogenic-properties,
↓ vasculogenesis,
↓ re-endothelialization,
similar osteogenic differentiation potential | [35] |
| | CD349 | FASC | ↑ Clonogenicity,
↑ multi-lineage differentiation | [36] |
| | GD2 | FACS | ↑ Clonogenicity,
↑ proliferation,
↑ adipogenesis,
↑ osteogenesis,
↑ gene expression: LPL, adipsin, collagen I, CBFA1, OC,
↑ content of positive cells: Sca-1+, CD105+, SSEA-1+, Nanog+,
↓ content of positive cells: CD34+, C-kit+, CD45+, CD11b+ | [40] |
| | GD2 | MACS | ↑ Clonogenicity,
↑ colony size,
↑ proliferation,
↑ gene expression: SSEA-4, Oct-4, Sox-2, Nanog, Nestin, GFAP, NSE,
↑ adipogenesis,
↑ osteogenesis | [37] |
| | Sca-1 | FACS | ↑ Clonogenicity,
↑ gene expression: NANOG, TERT, BMP2, Myf5,
↓ chondrogenesis,
↓ gene expression: Col2a1 | [41] |
| | Sca-1 | FACS | ↑ Clonogenicity | [50] |
| | Sca-1 | FCAS | ↑ Gene expression: Eng (CD105),
↓ gene expression: IL-6, Pdgfra, Ly6a, Itgb1, Itga5, CD44, Thy1(CD90) | [51] |
| | SSEA-3 | FACS | ↑ Differentiation into insulin-producing cells,
↑ pluripotent genes expression | [43] |
| | SSEA-3 | FACS | ↑ Migration toward injured liver cells,
↑ restoration of liver function in liver fibrosis model,
↑ in vivo spontaneous differentiation into hepatocyte | [52] |
| | SSEA-3 | FACS | ↑ Sphere formation | [22] |
| | SSEA-3 | FACS | ↑ Sphere formation,
↑ pluripotency,
↑ spontaneous expression and expression after differentiation of markers from three germ layers | [21] |
| | SSEA-3 | FACS | Better biodistribution,
↑ motor and cognitive functions of HIE rats | [45] |
| | SSEA-3 | FACS, MACS | Similar effects observed in both sorting methods
↑ sphere formation,
↑ pluripotency,
↑ neural differentiation | [42] |
| | SSEA-3 | MACS | ↓ Apoptosis and senescence after UV or H2O2 treatment,
↑ activation of damage repair system of DNA via non-homologous end joining | [53] |
| | SSEA-3 | MACS | ↑ Pluripotent genes expression | [48] |
| | SSEA-3 | MACS | ↑ Expression and secretion of growth factors,
↑ pluripotency gene expression,
↑ increased wound healing of skin ulcers | [44] |
| | SSEA-4 | FACS | No differences in proliferation, pluripotency genes expression, osteogenic differentiation, adipogenic differentiation | [34] |
| | SSEA-4 | FACS | ↑ Clonogenicity,
↑ proliferation | [54] |
| | SSEA-4 | FACS | ↑ Pluripotency and neural gene expression,
↑ viability of spheres,
smaller spheres formed,
no differences in proliferation and clonogenicity | In submission |
| | SSEA-4 | MACS | ↑ Adipogenesis | [33] |
| | SSEA-4 CD271 | FACS | ↑ Proliferation | [31] |
| | SSEA-4 CD271 | FACS | ↑ Clonogenicity,
↓ adipogenesis | [55] |
|
|
